Exploring the impact of bioactive compounds on endothelial dysfunction in hypertensive individuals: a comprehensive systematic review
Palavras-chave:
Resveratrol, Quercetin, Catechin, Endothelium, HypertensionResumo
Systemic Arterial Hypertension is considered the main risk factor for cardiovascular diseases and is also associated with a pro-oxidative environment and endothelial alterations. The objective of this review was to evaluate the evidence available in the literature regarding the impact of resveratrol, quercetin, and catechin consumption on endothelial function in individuals with arterial hypertension. The search was conducted using the PICOS strategy across the following databases: Science Direct, Pubmed, Scielo, and Lilacs. The inclusion criteria comprised adults and the elderly of both sexes, with a body mass index above 18.5 kg/m², diagnosed with arterial hypertension. Resveratrol and quercetin were found to have a positive effect on the vascular endothelium by increasing flow-mediated dilation. Additionally, quercetin alone led to a reduction in blood pressure among hypertensive individuals. However, due to limitations in the available studies, it was not possible to reach a conclusive result regarding catechin. Further studies are needed to evaluate its effect. Therefore, including food sources rich in resveratrol and quercetin may prove beneficial for individuals with this chronic non-communicable disease.
Downloads
Referências
BARROSO, W. K. S. et al. Diretrizes Brasileiras de Hipertensão Arterial – 2020. Arquivos Brasileiros de Cardiologia, v. 116, n. 3, p. 516–658, 3 mar. 2021.
BEHLING, E. et al. Flavonóide quercetina: aspectos gerais e ações biológicas. Alimentos e Nutrição, v. 15, 1 set. 2008.
BRÜLL, V. et al. Effects of a quercetin-rich onion skin extract on 24 h ambulatory blood pressure and endothelial function in overweight-to-obese patients with (pre-)hypertension: a randomised double-blinded placebo-controlled cross-over trial. British Journal of Nutrition, v. 114, n. 8, p. 1263–1277, 28 out. 2015.
BRÜLL, V. et al. Acute intake of quercetin from onion skin extract does not influence postprandial blood pressure and endothelial function in overweight-to-obese adults with hypertension: a randomized, double-blind, placebo-controlled, crossover trial. European Journal of Nutrition, v. 56, n. 3, p. 1347–1357, abr. 2017.
CARVALHO, A. P. V.; SILVA, V.; GRANDE, A. J. Avaliação do risco de viés de ensaios clínicos randomizados pela ferramenta da colaboração Cochrane. Diagn Tratamento, v. 18, p. 38–44, 1 jan. 2013.
CASEIRO, A. et al. Avaliação laboratorial do efeito antioxidante e anti-inflamatório do Resveratrol na função vascular. RevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia, v. 1, n. 2, p. 37–46, 27 nov. 2019.
CASTALDO et al. Red Wine Consumption and Cardiovascular Health. Molecules, v. 24, n. 19, p. 3626, 8 out. 2019.
CAVALCANTE, L. G. D. S. et al. Papel antiaterogênico do Resveratrol e seu efeito sobre a pressão arterial. Research, Society and Development, v. 10, n. 10, p. e213101018873, 8 ago. 2021.
DAI, H. et al. Sirtuin activators and inhibitors: Promises, achievements, and challenges. Pharmacology & Therapeutics, v. 188, p. 140–154, ago. 2018.
EDWARDS, R. L. et al. Quercetin Reduces Blood Pressure in Hypertensive Subjects1,. The Journal of Nutrition, v. 137, n. 11, p. 2405–2411, nov. 2007.
EGERT, S. et al. Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study. British Journal of Nutrition, v. 102, n. 7, p. 1065–1074, 14 out. 2009.
FUJITAKA, K. et al. Modified resveratrol Longevinex improves endothelial function in adults with metabolic syndrome receiving standard treatment. Nutrition Research, v. 31, n. 11, p. 842–847, nov. 2011.
GRASSI, D. et al. Black Tea Increases Circulating Endothelial Progenitor Cells and Improves Flow Mediated Dilatation Counteracting Deleterious Effects from a Fat Load in Hypertensive Patients: A Randomized Controlled Study. Nutrients, v. 8, n. 11, p. 727, 16 nov. 2016.
LARSON, A. et al. Acute, quercetin-induced reductions in blood pressure in hypertensive individuals are not secondary to lower plasma angiotensin-converting enzyme activity or endothelin-1: nitric oxide. Nutrition Research, v. 32, n. 8, p. 557–564, ago. 2012.
MARQUES, B. C. A. A. et al. Beneficial effects of acute trans-resveratrol supplementation in treated hypertensive patients with endothelial dysfunction. Clinical and Experimental Hypertension, v. 40, n. 3, p. 218–223, 3 abr. 2018.
MINZER, S.; ESTRUCH, R.; CASAS, R. Wine Intake in the Framework of a Mediterranean Diet and Chronic Non-Communicable Diseases: A Short Literature Review of the Last 5 Years. Molecules, v. 25, n. 21, p. 5045, 30 out. 2020.
OLIVEIRA, R. M. M. DE. Chá Verde na prevenção das doenças cardiovasculares. Comun. ciênc. saúde, p. 325–332, 2009.
PIRES, B. D. C. et al. CAMELLIA SINENSIS: BENEFÍCIOS NO AUXÍLIO AO TRATAMENTO DA OBESIDADE/CAMELLIA SINENSIS: BENEFITS IN AIDING THE TREATMENT OF OBESITY. Brazilian Journal of Development, v. 7, n. 2, p. 15411–15420, 2021.
REIS, R. C. et al. Compostos bioativos e atividade antioxidante de variedades melhoradas de mamão. Ciência Rural, v. 45, n. 11, p. 2076–2081, nov. 2015.
SAARENHOVI, M. et al. The effect of an apple polyphenol extract rich in epicatechin and flavan-3-ol oligomers on brachial artery flow-mediated vasodilatory function in volunteers with elevated blood pressure. Nutrition Journal, v. 16, n. 1, p. 73, dez. 2017.
SCHAAN, B. D. O papel da proteína quinase C no desenvolvimento das complicações vasculares do diabetes mellitus. Arquivos Brasileiros de Endocrinologia & Metabologia, v. 47, n. 6, p. 654–662, dez. 2003.
SENGER, A. E. V.; SCHWANKE, C. H. A.; GOTTLIEB, M. G. V. Chá verde (Camellia sinensis) e suas propriedades funcionais nas doenças crônicas não transmissíveis. Sci. med, p. 292–300, 2010.
SILVA, A. S.; ZANESCO, A. Exercício físico, receptores β-adrenérgicos e resposta vascular. Jornal Vascular Brasileiro, v. 9, n. 2, p. 47–56, jun. 2010.
SILVA-E-OLIVEIRA, J. et al. Low-dose resveratrol supplementation on heart rate variability in hypertensive volunteers: a controlled double-blind trial. Medical Express, v. 3, n. 6, 2016.
WONG, R. H. X. et al. Acute resveratrol supplementation improves flow-mediated dilatation in overweight/obese individuals with mildly elevated blood pressure. Nutrition, Metabolism and Cardiovascular Diseases, v. 21, n. 11, p. 851–856, nov. 2011.
YUGAR-TOLEDO, J. C. et al. Disfunção Endotelial e Hipertensão Arterial. v. 22, 2015.
ZHOU, B. et al. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants. The Lancet, v. 389, n. 10064, p. 37–55, jan. 2017.